# TECENTRIQ HYBREZA
> **BLA761347** · Biologics License Application · Sponsor: GENENTECH INC · Approved 2024-09-12
## Drug
- **FDA Application Number:** BLA761347
- **Application type:** Biologics License Application
- **Brand name:** TECENTRIQ HYBREZA
- **Generic name:** ATEZOLIZUMAB AND HYALURONIDASE-TQJS
- **Active ingredients:** ATEZOLIZUMAB AND HYALURONIDASE-TQJS
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GENENTECH INC
- **Manufacturer:** Genentech, Inc.
- **First approval:** 2024-09-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761347)
---
*MORVS · CC0 1.0*